✦ LIBER ✦

Trimetrexate in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus: A Phase II Study of the Gynecologic Oncology Group

✍ Scribed by Harriet O. Smith; John A. Blessing; Luis Vaccarello

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II evaluation of liposomal doxorub

✍ Gregory Sutton; John Blessing; Parviz Hanjani; Paul Kramer 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Prolonged Oral Etoposide in Recurrent or

✍ Peter G. Rose; John A. Blessing; John T. Soper; James F. Barter 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 68 KB

A phase II evaluation of trabectedin in

✍ Bradley J. Monk; John A. Blessing; Daron G. Street; Carolyn Y. Muller; James J. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 292 KB

Sunitinib malate in the treatment of rec

✍ Martee L. Hensley; Michael W. Sill; Dennis R. Scribner Jr.; Jubilee Brown; Rober 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Phase II Trial of Paclitaxel in Leiomyos

✍ Gregory Sutton; John A. Blessing; Harrison Ball 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Phase II Trial of Etoposide in Leiomyosa

✍ Tate Thigpen; John A. Blessing; Edgardo Yordan; Fidel Valea; Luis Vaccarello 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 51 KB